BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28083856)

  • 1. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA; Scott LJ
    Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.
    Scott LJ
    Drugs; 2012 Nov; 72(16):2141-65. PubMed ID: 23083111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.
    Carter NJ; Keating GM
    Paediatr Drugs; 2009; 11(4):271-91. PubMed ID: 19566111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
    Montejo M; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients].
    Fortún-Abete J
    Rev Iberoam Micol; 2009 Mar; 26(1):65-8. PubMed ID: 19463280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Why might micafungin be the drug of choice in pediatric patients?].
    Ramos Amador JT; Prieto Tato L; Guillén Martín S
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin.
    Jarvis B; Figgitt DP; Scott LJ
    Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Micafungin in invasive candidiasis among oncohematological patients].
    Jarque I; Angel Sanz M
    Rev Iberoam Micol; 2009 Mar; 26(1):75-7. PubMed ID: 19463282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micafungin - the newest echinocandin.
    Temesgen Z; Barreto J; Vento S
    Drugs Today (Barc); 2009 Jun; 45(6):469-78. PubMed ID: 19856528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.
    Xu G; Zhu L; Liao S; Ge T; Yang J
    Int J Antimicrob Agents; 2015 Dec; 46(6):631-41. PubMed ID: 26602452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
    Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
    Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
    [No Abstract]   [Full Text] [Related]  

  • 19. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.